FDA 483 - NWL Netherlands Services B.V. - October 18, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
NWL Netherlands Services B.V., a drug manufacturer in Hillegom, was cited for significant deficiencies across its quality control unit, computer system controls, and laboratory operations. The inspection revealed failures in record-keeping, change control, stability studies, OOS investigations, data integrity, component identity testing, and water system monitoring. These issues indicate a systemic lack of adherence to good manufacturing practices, posing risks to drug product quality and purity.
ID · 24d102b1-6384-4174-8707-773b565d7e18